Scientists have pinpointed a troubling mechanism: the same brain chemical doctors rely on to treat depression may be amplifying tinnitus, the chronic ringing or buzzing that plagues millions of people worldwide.
Researchers from Oregon Health & Science University and Anhui University used mice to trace how serotonin, a neurotransmitter celebrated for lifting mood, can also worsen auditory symptoms. The work, published in the Proceedings of the National Academy of Sciences, reveals a direct neural pathway between serotonin-producing neurons and the brain's hearing regions.
Tinnitus affects roughly 14% of the global population, with many cases considered severe. The relentless noise can spark anxiety, disrupt sleep, and derail daily functioning. The discovery carries immediate relevance for the tens of millions taking antidepressants, particularly SSRIs, which work by boosting serotonin.
Using optogenetics, a technique that employs light and fiber optics to activate specific brain cells, the team stimulated neurons that produce serotonin and observed activity surge in auditory processing regions. Mice exposed to this stimulation behaved as if experiencing tinnitus itself, showing heightened startle responses consistent with perceiving phantom sound.
The Medication Dilemma
The findings echo complaints from actual patients. Some people report that their tinnitus intensifies after starting serotonin-boosting medications, a link doctors have long suspected but never clearly understood until now.
Laurence Trussell, a professor of otolaryngology at OHSU, emphasized the practical stakes. "People with tinnitus should work with their prescribing physician to find a drug regimen that gives them a balance between relief of psychiatric symptoms like depression and anxiety, while minimizing the experience of tinnitus," he said.
The dilemma is real: SSRIs and similar antidepressants remain essential treatments for moderate to severe depression and anxiety. Stopping them is rarely an option. Yet the new research suggests that simply raising serotonin everywhere in the brain may carry an unintended cost.
Researchers point to a potential path forward. Zheng-Quan Tang, co-author and researcher at Anhui University, noted that "it may be possible to develop cell or brain region-specific drugs that steer the elevation of serotonin in some brain regions but not others." Such precision medicine could preserve the antidepressant benefits while sparing the auditory system from unwanted effects.
The team also demonstrated that deactivating the serotonin circuit significantly reduced tinnitus-like behavior in animals, suggesting that targeted interventions might eventually offer relief without forcing patients into an impossible choice between mental and auditory health.
Author Jessica Williams: "This study finally explains why some patients trade one problem for another when starting antidepressants, and it opens the door to smarter drugs that don't force that bargain."
Comments